IP Verse

Greiner, Elisabeth opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Greiner, Elisabeth

Patent Number:
EP3464373
Title:
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Jul 27, 2022
Patent Number:
EP3288980
Title:
Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Dec 10, 2021
Patent Number:
EP2968155
Title:
Tofacitinib Oral Sustained Release Dosage Forms
Applicant:
PFIZER INC.
Opposition Date:
Dec 2, 2021
Patent Number:
EP3134123
Title:
Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody
Applicant:
NEKTAR THERAPEUTICS
Opposition Date:
Nov 17, 2021
Patent Number:
EP3322731
Title:
Method Of Treating Cancer Using Immune Checkpoint Inhibitor
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Oct 13, 2021
Patent Number:
EP3050963
Title:
Process For Production Of Polypeptide By Regulation Of Assembly
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Jun 18, 2020

Competitors of Greiner, Elisabeth

BRISTOL-MYERS SQUIBB COMPANY

CHUGAI SEIYAKU KABUSHIKI KAISHA

NEKTAR THERAPEUTICS

Want to track Greiner, Elisabeth?

Feel free to send us a message here and we will get back to you